EGF Theramed Health Statistics

Total Valuation

CSE:TMED has a market cap or net worth of CAD 1.51 million. The enterprise value is 1.60 million.

Market Cap	1.51M
Enterprise Value	1.60M

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:TMED has 11.62 million shares outstanding. The number of shares has increased by 6.73% in one year.

Current Share Class	n/a
Shares Outstanding	11.62M
Shares Change (YoY)	+6.73%
Shares Change (QoQ)	+0.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.97
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.97

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-105.24%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	7.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.67% in the last 52 weeks. The beta is 1.14, so CSE:TMED's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-56.67%
50-Day Moving Average	0.08
200-Day Moving Average	0.12
Relative Strength Index (RSI)	86.17
Average Volume (20 Days)	444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-3,105
Operating Income	-233,266
Pretax Income	-440,839
Net Income	-404,087
EBITDA	n/a
EBIT	-233,266
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 20,166 in cash and 1.50 million in debt, giving a net cash position of -1.48 million or -0.13 per share.

Cash & Cash Equivalents	20,166
Total Debt	1.50M
Net Cash	-1.48M
Net Cash Per Share	-0.13
Equity (Book Value)	-2.94M
Book Value Per Share	-0.13
Working Capital	-2.94M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7,849
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:TMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.73%
Shareholder Yield	-6.73%
Earnings Yield	-26.76%
FCF Yield	n/a

Stock Splits

The last stock split was on July 11, 2022. It was a reverse split with a ratio of 0.05.

Last Split Date	Jul 11, 2022
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a